Life Sciences/Biotech

National Federation Independent Business-Michigan Opposes Medicaid Expansion

LANSING - Some two-thirds of National Federation of Independent Business-Michigan members do not want to see the state expand Medicaid eligibility, the group announced Thursday. Small business owners feared the plan would end up costing the state in the end, NFIB State Director Charlie Owens said. "The governor and his team deserve credit for trying

By |2013-03-14T00:00:00-04:00March 14th, 2013|Archive, Life Sciences/Biotech|

Dominick Colangelo Named CEO Of Aastrom Biosciences

ANN ARBOR - Aastrom Biosciences Inc. announced Wednesday that it has named Dominick Colangelo president and CEO. Dan Orlando, who had been interim CEO of Aastrom since November, will continue as chief commercial officer. Orlando replaced had replaced Tim Mayleben. Colangelo has more than 20 years of experience in the pharmaceutical industry, including almost 10

By |2013-03-07T00:00:00-05:00March 7th, 2013|Archive, Life Sciences/Biotech|

GOP Splits As House OKs Federal-State Exchange Partnership

LANSING - Michigan House Republicans were nearly evenly divided on Thursday over legislation allocating federal funding for a federal-state partnership on the federally mandated health insurance exchange under the Patient Protection and Affordable Care Act, but the legislation still passed by a comfortable margin. HB 4111 was passed by the House on a 78-31 vote,

By |2013-03-01T00:00:00-05:00March 1st, 2013|Archive, Life Sciences/Biotech|

Michigan House Committee OKs Money For Federal-State Partnership On Exchange

LANSING - The Michigan House Appropriations Committee took the first step in setting up a federally mandated health insurance exchange under the Affordable Care Act on Wednesday when it approved appropriating federal funds for a federal-state partnership. The committee voted 24-3 to report HB 4111 , which would accept $30.67 million in federal grant money

By |2013-02-27T00:00:00-05:00February 27th, 2013|Archive, Life Sciences/Biotech|

Medical Devices Makes Could Provide Cure For Dubai’s ailments?

GRAND RAPIDS - As local medical device companies look for new growth opportunities, they may do well to consider serving the burgeoning market in the Middle East, specifically Dubai. That?s the word from Don Beery, director of the two-dozen-member West Michigan Medical Device Consortium, who attended Arab Health 2013 in Dubai in late January. Beery

By |2013-02-21T00:00:00-05:00February 21st, 2013|Archive, Life Sciences/Biotech|

Perrigo Complete Buy Of Rosemont Pharmaceuticals For $283 Million

ALLEGAN - Perrigo Company announced that it has signed a definitive merger agreement and has completed the acquisition of Leeds, U.K.-based Rosemont Pharmaceuticals Ltd. for approximately $283 million in cash. Founded in 1967, Rosemont is a specialty and generic prescription pharmaceutical company focused on the manufacturing and marketing of oral liquid formulations. Rosemont's current portfolio

By |2013-02-16T00:00:00-05:00February 16th, 2013|Archive, Life Sciences/Biotech|

Carol Van Andel Named To Davenport University Board Of Trustees

GRAND RAPIDS ? Carol Van Andel, wife of Van Andel Institute Chairman David Van Andel, has been named to the Davenport University board of trustees. She serves as Executive Director of the David and Carol Van Andel Foundation and has provided leadership and support to dozens of regional and national organizations focused on education, the

By |2013-02-16T00:00:00-05:00February 16th, 2013|Archive, Life Sciences/Biotech|

Study: Michigan University R&D Corridor Creates $15.5 Billion In Economic Impact

LANSING - Michigan's University Research Corridor generated $15.5 billion in economic impact statewide, exceeded $2 billion in annual research expenditures and awarded more than 31,600 degrees in one year, placing it at or near the top of seven university innovation clusters in the U.S., according to a new Economic Impact Report released Wednesday. The URC

By |2013-01-24T00:00:00-05:00January 24th, 2013|Archive, Life Sciences/Biotech|